Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2016 - 2025)

Enanta Pharmaceuticals filings provide 13 years of Asset Utilization Ratio readings, the most recent being 0.22 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 19.55% to 0.22 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.22, a 19.55% increase, with the full-year FY2025 number at 0.2, up 23.26% from a year prior.
  • Asset Utilization Ratio hit 0.22 in Q4 2025 for Enanta Pharmaceuticals, down from 0.22 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.24 in Q1 2023 to a low of 0.17 in Q4 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.21 (2025), compared with a mean of 0.2.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 42.19% in 2021 and later grew 28.74% in 2025.
  • Enanta Pharmaceuticals' Asset Utilization Ratio stood at 0.21 in 2021, then grew by 7.4% to 0.23 in 2022, then decreased by 27.22% to 0.17 in 2023, then increased by 11.09% to 0.18 in 2024, then grew by 19.55% to 0.22 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.22 (Q4 2025), 0.22 (Q3 2025), and 0.21 (Q2 2025) per Business Quant data.